A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS-Reference-Cited by-同舟云学术

A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS

Published:2013-06 Issue:3 Volume:6 Page:538-545
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ Arrhythm Electrophysiol

Author:

Muto Carmine¹,Solimene Francesco¹,Gallo Paolo¹,Nastasi Maurizio¹,La Rosa Concetto¹,Calvanese Raimondo¹,Iengo Raffaele¹,Canciello Michelangelo¹,Sangiuolo Raffaele¹,Diemberger Igor¹,Ciardiello Carmine¹,Tuccillo Bernardino¹

Affiliation:

1. From the Ospedale S.Maria di Loreto Mare, Napoli, Italy (C.M., R.C., R.I., M.C., B.T.); Casa di cura “Montevergine” Mercogliano (AV), Italy (F.S.); CdC Villa dei Fiori, Acerra (NA), Italy (P.G.); CdC Villa Bianca, Bari, Italy (M.N.); CdC Villa Verde Taranto, Italy (C.L.R.); Ospedale Buon Consiglio Fatebenefratelli, Napoli, Italy (R.S.); Policlinico S. Orsola-Malpighi, Bologna, Italy (I.D.); and Boston Scientific, Milano, Italy (C.C.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction

2. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.;Authors/Task Force Members;Eur Heart J,2010

3. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

4. Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

5. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with “mid-range” QRS duration;Heart Rhythm;2024-06

2. Quest for the ideal assessment of electrical ventricular dyssynchrony in cardiac resynchronization therapy;Journal of Molecular and Cellular Cardiology Plus;2024-03

3. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure;Heart Rhythm;2023-09

4. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure;Journal of Arrhythmia;2023-08-02

5. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2022-05-03